NCT01094834

A Multiple Dose Study of DWP05195 in Healthy Adult Subjects

A Multiple Dose Study To Determine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP05195 in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: Male
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of multiple administered DWP05195 in healthy volunteers

Conditions

• Healthy Adult Volunteers

Interventions

Type	Name	Description
DRUG	DWP05195	tablets, oral administration, multiple administration

Timeline

• Start date: 2010-04-01
• Primary completion: 2010-10-01
• First posted: 2010-03-29
• Last updated: 2011-02-09